Efficacy Study of Prolotherapy vs Corticosteroid for Tennis Elbow
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
The purpose of the research is to study the effects of two different injection therapies for the treatment of lateral epicondylitis (tennis elbow). Specifically, we will look at which therapy provides better short and long-term relief of pain, which treatment allows better function and less disability, and which treatment gives back better strength in the affected hand. Each subject will receive only one of the two treatments. Although both of these treatments are usually very well tolerated, it is important to make this comparison because it is believed that one of these therapies may have better long term effectiveness, with a lower cost, and smaller number of potential side effects.
Condition or disease
Drug: ProlotherapyDrug: Local Corticosteroid Therapy
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years to 75 Years (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
age criteria >18yo, <75yo, history of pain > 3 months, < 2 years; pain on resisted extension of wrist and/or middle finger test, (resisted extension of middle finger at the MCP joint)
local tenderness to palpation at the lateral epicondyle
subject can read and write in English.
history of steroid injections within 6 months prior to intervention;
other arm/forearm pathology such as radial nerve compression; pregnancy/nursing;
known thrombocytopenia, coagulopathy, or bleeding diathesis; history of diffuse pain syndrome;
history of Inflammatory Arthropathy;
Workman's Compensation (RSI) > 2 years; patients with litigation pending/planned; patients who are unable to return for F/U;
intolerance/allergy to local anesthetics or injection corticosteroids; fear of needles; untreated depression;
history of narcotic use for pain management greater than 1 month or history of narcotic abuse problem.